Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024178 · ClinicalTrials.gov registry record · NA

Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT02024178: Completed NA study, sponsored by NYU Langone Health.

NCT02024178 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024178, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

This pilot clinical trial studies ultrasound imaging in finding prostate cancer in patients undergoing surgery. Diagnostic procedures, such as ultrasound imaging, may help find and diagnose prostate cancer. This study will serve as an analysis of the Histo-Scanning technology for the purpose of determining its ability to identify sites of prostate cancer at the time of prostate ultrasound.

Primary Outcome

Compare location and concordance of findings on pre-op MRI \& Histoscan with radical prostatectomy specimen

Interventions

  • PROCEDURE Ultrasound Imaging

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2011-06
Est. Completion 2012-05
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT02024178 record still lists

NCT02024178 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Ultrasound Imaging is the first listed.

NCT02024178 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02024178 about?

NCT02024178 is a clinical study titled "Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery". This pilot clinical trial studies ultrasound imaging in finding prostate cancer in patients undergoing surgery. Diagnostic procedures, such as ultrasound imaging, may help find and diagnose prostate cancer. This study will serve as an analysis of the Histo-Scanning technology for the purpose of dete...

What is the current status of trial NCT02024178?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2011-06. Estimated completion is 2012-05.

What interventions are being tested in trial NCT02024178?

The interventions under investigation include: Ultrasound Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT02024178?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02024178's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02024178, the US trial registry maintained by the National Library of Medicine. NCT02024178 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.